Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Masaya Takanashi
Observed names:
M. Takanashi,
Masaya TAKANASHI
Institutions:
National Cancer Centre Japan,
National Cancer Center Hospital East,
Nippon Kayaku (Japan),
National Cancer Center Hospital
Observed institutions:
National Cancer Centre Japan,
National Cancer Center Hospital East,
Nippon Kayaku (Japan),
National Cancer Center Hospital
OpenAlex ID:
A5080426166
Phase I Study of NK012, a Novel SN-38–Incorporating Micellar Nanoparticle, in Adult Patients with Solid Tumors
2010
·
Tetsuya Hamaguchi
, Toshihiko Doi
, et al.
·
Clinical Cancer Research
·
156
Identification of the Carboxymethyllysine Residue in the Advanced Stage of Glycated Human Serum Albumin.
1992
·
Masaya TAKANASHI
, Tamiko SAKURAI
, et al.
·
Chemical and Pharmaceutical Bulletin
·
7
PDF
Modification of glycophorin A during oxidation of erythrocyte membrane
1990
·
Masatoshi Beppu
, Masaya Takanashi
, et al.
·
Biochimica et Biophysica Acta (BBA) - Biomembranes
·
6
POSTER Phase I dose escalation study of NK012, polymer micelle of irinotecan metabolite SN-38, in patients with advanced cancer
2008
·
D. Toshihiko
, N. Fuse
, et al.
·
European Journal of Cancer Supplements
·
3
Site-specific cleavage of glycated human serum albumin in the presence of iron.
1992
·
Tamiko SAKURAI
, Masaya TAKANASHI
, et al.
·
Chemical and Pharmaceutical Bulletin
·
2
PDF
Two independent phase I trials of NK012, SN-38 incorporating micellar nanoparticle for patients with advanced cancer, opened in Japan and United States of America
2009
·
Yousuke Horita
, Tetsuya Hamaguchi
, et al.
·
Drug Delivery System
PDF
Show more works
View as search
Works count:
6
Citation count:
174
H-index:
3
I10-index:
1
Year
Topic
Type